High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension

Hypertension Research

Volumn 30, Issue 2, 2007, Pages 125-131

  Anan, Futoshi ^a,b   Yonemochi, Hidetoshi ^a   Masaki, Takayuki ^a   Takahashi, Naohiko ^a   Fukunaga, Naoya ^b   Teshima, Yasushi ^b   Iwao, Tetsu ^b   Kaneda, Koji ^b   Eshima, Nobuoki ^c   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

Essential hypertension; High density lipoprotein cholesterol; Insulin resistance; Left ventricular hypertrophy

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK; TRIGLYCERIDES; URIC ACID;

EID: 34047230136     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.125     Document Type: Article

References (39)

1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
3. Denker PS, Pollock VE: Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 1992; 152: 1649-1651.
4. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H: Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 1999; 17: 1153-1160.
5. Cuspidi C, Macca G, Sampieri L, et al: Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001; 19: 1539-1545.
6. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
7. Eto M, Toba K, Akishita M, et al: Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1-7.
8. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H: Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26: 669-676.
9. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101-107.
10. Horio T, Miyazato J, Kamide K, Takiuchi S, Kawano Y: Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens 2003; 16: 938-944.
11. Schillaci G, Vaudo G, Reboldi G, et al: High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265-2270.
12. Chen W, Srinivasan SR, Elkasabany A, Berenson GS: Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescent, and young adults: the Bogalusa Heart Study. Am J Epidemiol 1999; 150: 667-674.
13. Steinberger J, Moorehead C, Katch V, Rocchini AP: Relationships between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995; 126: 690-695.
14. Pickering TG, Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1-11.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001; 285: 2486-2497.
16. Tochikubo O, Ikeda A, Miyajima E, Ishii M: Effect of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324.
17. Kohara K, Nishida W, Maguchi M, Hiwada K: Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808-814.
18. Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
19. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
20. Verdecchia P, Schillaci G, Porcellati C, Cuccurullo O, Cosco C, Perticone F: Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
21. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Taniguchi A, Fukushima M, Sakai M, et al: Remnant-like particle cholesterol, triglyceride, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766-1769.
23. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
24. Grundy SM: Hypertriglycemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
25. Scherrer U, Sartori C: Insulin as vascular and sympathoexcitatory hormone: implication for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
26. Rocchini AP, Katch V, Kveselis D, et al: Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14: 367-374.
27. Hsueh WA, Law RE: Insulin signaling in the arterial wall. Am J Cardiol 1999; 84: 21J-24J.
28. Ito H, Hiroe M, Hirata Y, et al: Insulin-like growth factor-1 induces cardiac hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-1721.
29. Facchini FS, Stoohs RA, Reaven GM: Enhanced sympathetic nervous system activity. Am J Hypertens 1995; 9: 1013-1017.
30. Takahashi N, Nakagawa M, Saikawa T, et al: Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 2001; 38: 232-237.
31. Douglas P, Tallant B: Hypertrophy, fibrosis and diastolic dysfunction in early canine experiment hypertension. J Am Coll Cardiol 1991; 17: 117-119.
32. Hoshide S, Kario K, Hoshide Y, et al: Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003; 16: 434-438.
33. Fagard R, Staessen J, Thijis L, Amery A: Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring: a metaanalysis of comparative studies. Am J Hypertens 1995; 8: 533-540.
34. Morgan HE, Baker KM: Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13-25.
35. Ono A, Fujita T: Predictors of controlled ambulatory blood pressure in treated hypertensive patients with uncontrolled office blood pressure. Hypertens Res 2004; 27: 805-811.
36. Toikka JO, Ahotupa M, Viikari JS, et al: Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo. LDL-oxidant in healthy young men. Atherosclerosis 1999; 147: 133-138.
37. Perticone F, Maio R, Ceravolo R, et al: Relationship between left ventricular mass and endothelium-dependent vasodilatation in never-treated hypertensive patients. Circulation 1999; 99: 1991-1996.
38. Shigematsu Y, Norimatsu S, Ohtsuka T, Okayama H, Higaki J: Sex-related differences in the relations of insulin resistance and obesity to left ventricular hypertrophy in Japanese hypertensive patients. Hypertens Res 2006; 29: 499-504.
39. Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.